Paul Phull

Managing Director, Europe and Executive Vice-President Sinclair Pharmaceuticals Ltd

Mr Phull has overall responsibility for Sinclair Group commercial operations and in particular for Sinclair´s own sales and marketing companies in Europe. In addition, Mr Phull is responsible for corporate development, looking for acquisition and collaboration opportunities on a global basis to develop the Company´s commercial objectives. Mr Phull is an experienced executive in international pharmaceutical commercialisation, having worked in the healthcare industry for over 20 years.

Alan Olby

Finance Director and Company Secretary

Mr Olby has responsibility for the finance operations across the Group, including financial reporting, financing and tax planning. Mr Olby joined Sinclair in September 2005 having gained experience in the biotech sector working at Xenova Group plc and KS Biomedix plc. He qualified as a chartered accountant in 1996 and subsequently worked in corporate finance at Deloitte, supporting public and private companies with due diligence, working capital reviews and stock exchange transactions.

Marco Mastrodonato

Executive Vice-President

Mr Mastrodonato has headed up the Business Development, Licensing and Products Development Division of Sinclair Pharma since the acquisition of Propharma Srl by the Company in May 2001. In 2004 with the acquisition of Euroderm Spa, the operating company in Italy (now Sinclair Srl), Mr Mastrodonato was nominated Chairman of the Board for the Local Italian Subsidiary which is responsible for detailing the Sinclair Dermatology products in the Italian Market. Mr Mastrodonato founded Propharma Srl in 1999 and invented Gelclair, Aloclair, Xclair, Atopiclair, Sebclair, Dermachronic (a preservative-free range of hypoallergenic toiletries for paediatrics), Sinlice, Decapinol Perioapplicator, Decapinol Gel and Decapinol Toothpaste. Between 1996 and 1998 Mr Mastrodonato worked as a consultant for Carrington Laboratories Inc, a US research-based bio-pharmaceutical company, licensing and exporting products from the US to Europe. Prior to 1998, Mr Mastrodonato founded Protema Spa, an Italian agro-chemical company. Between 1989 and 1996 he founded the European Operation of an international clinical research organisation, AAI Pharma Inc. and between 1987 and 1989 he worked for the independent company OEMF Spa, publishers of the pharmaceutical directory, Informatore Farmaceutico

Christophe Foucher

General Manager, Sinclair Pharma France, Southern Europe Director

Mr Foucher was appointed General Manager in January 2008. In July 2008, he was appointed Southern Europe Director in charge of operations in Italy, Spain and Portugal. Mr Foucher has 14 years´ experience in the pharmaceutical industry at senior level in Europe, Africa and Asia. Mr Foucher has a doctorate degree in Pharmacy, an INSEAD diploma in Finance and an MBA from IAE. He is fluent in English, French and Italian.

Mike Killeen

Executive Vice President North America

Mr Killeen joined following the acquisition of Propharma Srl in May 2001. At Propharma Srl, Mr Killeen held the position of Vice President of Sales and Marketing for the US and Pacific Rim. Prior to joining Propharma Srl, Mr Killeen was Director of Sales and Marketing at Carrington Laboratories Inc., prior to which he was Director of Business Development at Horizon Medical Inc.